MagVenture receives FDA clearance for OCD

ALPHARETTA, GA, Aug. 11, 2020 -- (Healthcare Sales & Marketing Network) -- FDA has cleared MagVenture TMS Therapy® for adjunct treatment of Obsessive-Compulsive Disorder (OCD). This marks the second indication in the US for the Danish medical device c... Devices, Neurology, FDA MagVenture, TMS Therapy, Transcranial Magnetic Stimulation, Obsessive-Compulsive
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news